Medvarsity Logo
Human Papilloma Virus Vaccine for Prevention of Cancer: The future and the Challenges

CASE DISCUSSION

Human Papilloma Virus Vaccine for Prevention of Cancer: The future and the Challenges

United Arab Emirates flagPresented United Arab Emirates by Dr. Krishi Gowdra Revanna Siddappa

Views

3,632

Case Description

Case Summary

  • HPV is a non-enveloped, double-stranded DNA virus with over 200 genotypes, some of which can cause cancers of the cervix, vagina, vulva, penis, anus, and oral cavity. While most people clear HPV infections within 6-12 months, chronic infections can lead to cancer over 15-20 years, influenced by age, parity, STIs, and smoking.

Speaker Profile

Dr. Krishi Gowdra Revanna Siddappa

Dr. Krishi Gowdra Revanna Siddappa

Specialist Obstetrics and Gynecology, Zulekha Hospital

Disclosures

Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.